You are here

  • Home
  • Archive
  • Volume 9, Issue 11
  • The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis

Article metrics

Article menu

Download PDFPDF

XML
Paediatrics
Protocol
The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis

 

Online download statistics by month:

Online download statistics by month: November 2019 to September 2024

AbstractFullPdf
Nov 201928828459
Dec 20191009719
Jan 2020948813
Feb 2020908613
Mar 2020787313
May 202027279
Jun 2020272411
Jul 2020231911
Aug 202032028426
Sep 202036326
Oct 202035348
Nov 2020383313
Dec 202020196
Jan 202120178
Feb 2021292312
Mar 2021343210
Apr 2021323111
May 2021241914
Jun 2021404011
Jul 2021434012
Aug 2021211913
Sep 202131278
Oct 2021272427
Nov 2021343126
Dec 202124247
Jan 202236354
Feb 202224204
Mar 202233288
Apr 202248433
May 202230277
Jun 2022443714
Jul 2022232310
Aug 2022353013
Sep 2022302718
Oct 2022413312
Nov 2022484417
Dec 202222183
Jan 202328226
Feb 2023443511
Mar 202332296
Apr 202319169
May 2023473314
Jun 202328283
Jul 202324246
Aug 202327239
Sep 202321204
Oct 202325216
Nov 202331279
Dec 2023282712
Jan 202434329
Feb 2024262313
Mar 2024292469
Apr 2024392527
May 2024271915
Jun 2024363310
Jul 2024363312
Aug 2024443418
Sep 2024282111
Total26022341758